These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 21813407)
1. Targeting the right treatments for neuroblastoma. Nelson NJ J Natl Cancer Inst; 2011 Aug; 103(16):1218-21. PubMed ID: 21813407 [No Abstract] [Full Text] [Related]
2. [Management strategy in neuroblastoma]. Balwierz W Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038 [TBL] [Abstract][Full Text] [Related]
3. Ten challenges in the management of neuroblastoma. Gains J; Mandeville H; Cork N; Brock P; Gaze M Future Oncol; 2012 Jul; 8(7):839-58. PubMed ID: 22830404 [TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma: biology, prognosis, and treatment. Park JR; Eggert A; Caron H Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317 [TBL] [Abstract][Full Text] [Related]
5. CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma. Miles SA; Sandler AD Adv Drug Deliv Rev; 2009 Mar; 61(3):275-82. PubMed ID: 19186194 [TBL] [Abstract][Full Text] [Related]
7. New therapeutic targets for the treatment of high-risk neuroblastoma. Wagner LM; Danks MK J Cell Biochem; 2009 May; 107(1):46-57. PubMed ID: 19277986 [TBL] [Abstract][Full Text] [Related]
8. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study. Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154 [TBL] [Abstract][Full Text] [Related]
9. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569 [TBL] [Abstract][Full Text] [Related]
10. [Discovery of a gene mutation associated with familial neuroblastoma]. Nau JY Rev Med Suisse; 2008 Sep; 4(169):1888. PubMed ID: 18831412 [No Abstract] [Full Text] [Related]
16. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma. Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826 [TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry. Gigliotti AR; Di Cataldo A; Sorrentino S; Parodi S; Rizzo A; Buffa P; Granata C; Sementa AR; Fagnani AM; Provenzi M; Prete A; D'Ippolito C; Clerico A; Castellano A; Tonini GP; Conte M; Garaventa A; De Bernardi B Eur J Cancer; 2009 Dec; 45(18):3220-7. PubMed ID: 19767197 [TBL] [Abstract][Full Text] [Related]
18. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma. Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021 [TBL] [Abstract][Full Text] [Related]
19. Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials. Simon T; Berthold F; Borkhardt A; Kremens B; De Carolis B; Hero B Pediatr Blood Cancer; 2011 Apr; 56(4):578-83. PubMed ID: 21298742 [TBL] [Abstract][Full Text] [Related]
20. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients. Molina B; Alonso L; Gonzalez-Vicent M; Andion M; Hernandez C; Lassaletta A; Cormenzana M; Lopez-Ibor B; Villa M; Molina J; Diaz MA Pediatr Hematol Oncol; 2011 Mar; 28(2):115-23. PubMed ID: 21299340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]